Restoration of flow following haemodialysis catheter thrombus. Analysis of rt-PA infusion in tunnelled dialysis catheters

Journal of Clinical Pharmacy and Therapeutics

Volumn 29, Issue 6, 2004, Pages 517-520

  Davies, J ^a   Casey, J ^a   Li, C ^a   Crowe, A V ^a   McClelland, P ^a  

^a ARROWE PARK HOSPITAL   (United Kingdom)

Author keywords

Catheter; Haemodialysis; rt PA

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; STREPTOKINASE; UROKINASE;

ARTICLE; BLOOD FLOW; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; EYE DISEASE; HEMODIALYSIS; HEMODIALYSIS CATHETER THROMBUS; HUMAN; RECTUM HEMORRHAGE; THROMBUS; TREATMENT OUTCOME; VASCULAR ACCESS; VASCULAR PATENCY;

CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; EQUIPMENT FAILURE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TISSUE PLASMINOGEN ACTIVATOR; VENOUS THROMBOSIS;

EID: 10844264030     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2004.00581.x     Document Type: Article

References (13)

1. Webb A, Mubarak A, Russell GI (2001) A protocol of urokinase infusion and warfarin for the management of the thrombosed haemodialysis catheter. Nephrology, Dialysis, Transplantation, 16, 2075-2078.
2. Twardowski ZJ (1998) High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters. American Journal of Kidney Diseases, 31, 841-847.
3. Savader SJ, Haikal LC, Ehrman KO, Porter DJ, Oteham AC (2001) Treatment of hemodialysis catheter-associated fibrin sheaths: treatment with a low-dose rt-PA infusion. Journal of Vascular and Interventional Radiology, 12, 711-715.
4. Daeihagh P, Jordan J, Chon J, Rocco M (2000) Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters. American Journal of Kidney Disease, 36, 75-79.
5. Haire WD, Atkinson JB, Stephens LC, Kotulak GD (1994) Urokinase verses recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blinded, randomised trial. Thrombosis and Haemostasis, 72, 543-547.
6. Ponec D, Irwin D, Haire WD, Hill PA, Li X, McClusky ER (2001) Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial; the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. Journal of Vascular and Interventional Radiology, 12, 951-955.
7. Clase CM, Crowtheer MA, Ingram AJ, Cina CS (2001) Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review. Journal of Thromb Thrombolysis, 11, 127-136.
8. Eyric H, Walton T, Macon EJ, Howe A (2002) Alteplase versus urokinase in restoring blood flow in hemodialysis catheter thrombosis. American Journal of Health-Syst Pharm, 59, 1437-1440.
9. Hoshal VL Jr, Ause RG, Hoskins PA (1971) Fibrin sleeve formation on indwelling subclavian central venous catheters. Archives of Surgery, 102, 353-357.
10. Prabhu PN, Kerns SR, Sabatelli FW, Hawkins IF, Ross EA (1997) Long-term performance and complications of the tesio twin catheter systems for haemodialysis access. American Journal of Kidney Diseases, 30, 213-218.
11. Atherikul K, Schwab SJ, Conlon PJ (1998) Adequacy of haemodialysis with cuffed central-vein catheters. Nephrology, Dialysis, Transplantation, 13, 745-749.
12. The Renal Association (2002) Treatment of adults and children with renal failure, 3rd edn. London: The Lavenham Press Ltd.
13. Timoney JP, Malkin MG, Leone DM et al. (2002) Safe and cost effective use of alteplase for the Clearence of central venous access devices. Journal of Clinical Oncology, 20, 1918-1922.